top of page


Name of Media:

Hysteroscopic morcellation of uterine leiomyomas (fibroids)


National Institute for Health and Care Excellence - NICE

Publisher or Source:

National Institute for Health and Care Excellence - NICE

Type of Media:

Medical Professional Education

Media Originally for:

Critical Care Physicians,Nurses and/or Other Critical Care Medical Professionals

Country of Origin:

United Kingdom of Great Britain and Northern Ireland (the)

Primary Focus of Media:

Pre-Use of PICS Designation

COVID-19 Related:



The National Institute for Health and Care Excellence (NICE) published interventional procedure guidance 486 on hysteroscopic morcellation of uterine fibroids in April 2014 but later withdrew the guidance because there was an error in the patient commentary considered by the Committee when it made its recommendations. 
NICE interventional procedure guidance 522 on hysteroscopic morcellation of uterine leiomyomas (fibroids) was published in June 2015 and replaces interventional procedure guidance 486.
Uterine leiomyomas (also known as uterine myomas or fibroids) are benign tumours that develop within the uterine wall. They can be single or multiple. They are one of the most common gynaecological problems among women in the UK. They are often asymptomatic but they can cause symptoms such as menorrhagia, intermenstrual bleeding, a feeling of pelvic pressure, pain, and urinary incontinence. They may also be associated with reproductive problems such as subfertility and miscarriage.
Treatment depends on whether the leiomyomas cause symptoms and on the woman’s desire for future childbearing. Asymptomatic leiomyomas need no treatment. Depending on their size, number and location, symptomatic leiomyomas can be managed by hysterectomy (surgical removal of the uterus) or myomectomy (surgical removal of the leiomyomas). Smaller submucous leiomyomas can be removed by hysteroscopic resection. Uterine artery embolisation may also be used. Other treatments include endometrial ablation, using energy such as microwave or heat, which may be suitable for some leiomyomas. Hormone-based treatments may be used on a short-term basis to relieve symptoms, or to shrink the leiomyomas before surgery or other interventional treatment.
Coding and clinical classification codes for this guidance

To view the attached Video media file, Click Icon:

PostICU, Inc's library staff reviewed this copyrighted material contained in the library and reasonably believes that its inclusion in our library complies with the "Fair Use Doctrine" because: (1) our library's is for nonprofit and educational purposes; (2) the nature of the copyrighted work is related to our mission; (3) the amount and substantiality of the portion used in relation to the copyrighted work as a whole is fair and reasonable; and (4) the potential market for or value of the copyrighted work will if impacted, should be enhanced, by its presence in our library.

bottom of page